DB Power and LPA announce strategic partnership to globally expand solutions for issuers of structured retail products

Real Time Search
CES A80 :
CES HKMI :
CES 120 :
Total Turn.

02315 BIOCYTOGEN-B

Trading Add to Porfolio
Index Constituent : None
Major Shareholders Shen Yuelei (27.19%)
SDIC Venture Capital Management Co., Ltd. (18.26%)
[03968] China Merchants Bank Company Limited (18.01%)
He Chengming & Associates (7.71%)
[02628] China Life Insurance Company Limited (5.89%)		 Sector Health Care & Biotechnology
Web Site http://www.biocytogen.com.cn/ Tel (86 10) 5696-7601
Email ir@bbctg.com.cn Fax (86 10) 5696-7666
Related Equities N/A
Principal Activities Principally engaged in providing gene editing services, pre-clinical pharmacology and efficacy evaluation services, animal models selling, antibody development and innovative biologic drug research and development.

Consolidated List of Substantial Shareholders

Name Number of Shares Interested % of Issued Share Capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool

Complete List of Directors

Director's Name Number of Shares Interested % of issued share capital (%) Date of Last Notice Filed (Y/M/D)
Last Update :
Note : (L) - Long Position (S) - Short Position (P) - Lending Pool
Back to Top